微生物组样本製备技术市场－全球产业规模、份额、趋势、机会和预测：按产品、工作流程、应用、疾病类型、最终用户、地区和竞争格局划分，2021-2031年

全球微生物组样本製备技术市场预计将从 2025 年的 2.5 亿美元成长到 2031 年的 3.7 亿美元，复合年增长率为 6.75%。

此领域涵盖用于从各种生物基质中分离、纯化和稳定高品质微生物核酸的专用试剂、试剂盒和自动化设备，以便进行后续分析。推动该领域发展的主要因素是生活方式相关慢性疾病发病率的上升以及对需要精确微生物分析的个人化疗法的需求日益增长。此外，加强产业合作也提升了研究能力。例如，皮斯托亚联盟（Pistoia Alliance）在2024年报告称，已与200多个成员机构在竞争前计划方面开展合作，包括构建微生物组介导的药物代谢资料库，以加速治疗方法的发现。

儘管呈上升趋势，但由于缺乏普遍标准化的通讯协定采集和处理方案，该行业仍面临许多挑战。微生物样本固有的多样性常常导致不同研究间数据不一致和提取偏差，从而丧失了监管检验和商业性扩充性所需的可重复性。

市场驱动因素

微生物组研究资金筹措和投资的激增是全球微生物组样本製备技术市场的关键催化剂。随着肠道健康与整体健康之间联繫的日益清晰，越来越多的资本投入到致力于标准化工作流程和开发新治疗方法的生物技术公司。这些资金支持使公司能够优化样本采集和提取过程，并确保产生临床检验所需的高精度数据。这一趋势在Biohm Technologies公司尤为明显，该公司于2025年4月完成B轮融资，筹集了452万美元，并宣布扩大其微生物组数据和技术产品范围。这正在加速开发能够处理复杂基质的先进试剂盒。

此外，次世代定序技术的突破性进展催生了对能够应对现代平台高通量和高灵敏度要求的上游工程解决方案的需求，从而加速了市场扩张。随着定序工具成本效益和数据产出能力的提升，处理瓶颈问题也随之出现，而自动化、高效的样品製备系统对于克服这些瓶颈至关重要。主要企业的强劲财务业绩印证了这一趋势。牛津奈米孔科技公司（Oxford Nanopore Technologies）公布的截至2025年6月的财年中期业绩显示，剔除外汇波动影响后，其营收成长了28.0%；Illumina公司公布的截至2025年10月的财年季度营收为10.8亿美元。这些数据凸显了可靠的样品製备在支持不断发展的基因组分析生态系统中发挥的关键作用。

市场挑战

全球微生物组样本製备技术市场面临的主要障碍是样本采集和调查方法缺乏普遍统一的标准。这种不一致性造成了严重的瓶颈，损害了资料的完整性和可重复性。当不同的实验室采用不同的萃取试剂盒和稳定化技术时，最终得到的微生物谱往往有显着差异，难以区分真实的生物讯号和技术误差。根据皮斯托亚联盟 (Pistoia Alliance) 2024 年的一项调查，48% 的生命科学专业人士认为，缺乏元资料标准化是有效利用实验数据进行研发的主要障碍，阻碍了检验临床生物标记所需的跨研究比较。

因此，这种波动性阻碍了监管核准和商业化进程，并限制了市场发展。监管机构需要可靠且可重复的数据来确认基于微生物组的诊断和治疗方法的安全性和有效性，但由于缺乏统一的通讯协定，製造商难以证明其一致性。这种不确定性抑制了投资意愿，减缓了样本製备技术在临床环境中的应用，并最终限制了整体市场收入潜力。

市场趋势

针对低生物量环境的专用萃取解决方案的开发正在改变市场格局，其解决的是处理微生物含量极低的样本（例如皮肤和血液）所面临的挑战。传统试剂盒通常面临这些基质中宿主DNA与微生物DNA比例过高的难题，因此需要高灵敏度和优化的通讯协定来确保获得高品质的数据。这项技术需求正在推动旨在提高提取效率的策略合作。例如，2024年11月，凯杰公司（Qiagen）和麦基尔大学宣布合作，共同开发专门针对低生物量样本的方法，旨在加强其在价值18亿美元的北美微生物组研究领域的影响力。

同时，微流体技术在单细胞微生物组製备中的应用日益广泛，旨在揭示传统批量定序中常被忽略的异质性。透过在微流体液滴中分离单一细菌，这些平台能够精确绘製复杂群落中菌株特异性基因表现和代谢功能图。正如我们在2024年12月发表的关于新兴技术的报导中所强调的，M20 Genomics公司透露，其VITA单细胞转录组平台已在全球范围内处理了超过7000个微生物样本。这表明这些工作流程具有扩充性和快速应用性，能够有效区分不同物种的功能差异。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球微生物组样本製备技术市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依产品分类（设备、耗材）
  • 工作流程分解（样品萃取/分离、样品定量、品管、碎片化、样品製备、目标浓缩、文库定量、混合）
  • 应用特定定序（DNA定序、全基因测序、RNA定序、甲基化定序、宏总体基因体学、单细胞定序等）
  • 疾病类型（自体免疫疾病、癌症、消化系统疾病、其他）
  • 依最终用户（製药/生物技术、诊断检查室、其他）划分
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美微生物组样本製备技术市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲微生物组样本製备技术市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区微生物组样本製备技术市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲微生物组样本製备技术市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美微生物组样本製备技术市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球微生物组样本製备技术市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Illumina
• QIAGEN
• Thermo Fisher Scientific
• Zymo Research
• Molzym
• Omega Bio-tek
• Promega
• PerkinElmer
• New England Biolabs
• Kapa Biosystems

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Microbiome Sample Preparation Technology Market is projected to expand from USD 0.25 Billion in 2025 to USD 0.37 Billion by 2031, registering a CAGR of 6.75%. This sector encompasses specialized reagents, kits, and automated instrumentation designed to isolate, purify, and stabilize high-quality microbial nucleic acids from various biological matrices for subsequent analysis. Growth is primarily propelled by the rising incidence of chronic lifestyle-related conditions and the growing need for personalized medical treatments that require accurate microbial profiling. Furthermore, enhanced industrial cooperation is strengthening research capacities; for instance, the Pistoia Alliance reported in 2024 that it coordinated with over 200 member organizations on pre-competitive initiatives, such as creating a microbiome-mediated drug metabolism database to facilitate therapeutic discovery.

Despite this upward trend, the industry faces a substantial hurdle due to the absence of universally standardized protocols for sample collection and processing. The intrinsic diversity of microbial samples frequently leads to inconsistent data and extraction biases across different studies, which compromises the reproducibility needed for regulatory validation and commercial scalability.

Market Driver

The surge in funding and investment for microbiome research serves as a crucial catalyst for the Global Microbiome Sample Preparation Technology Market. As the connection between gut health and systemic well-being becomes clearer, capital is increasingly directed toward biotechnology firms aiming to standardize workflows and create new therapeutic formulations. This financial support enables companies to optimize sample collection and extraction procedures, ensuring the generation of high-fidelity data necessary for clinical validation. This trend is exemplified by Biohm Technologies, which announced in April 2025 that it had raised $4.52 million in a Series B round to broaden its microbiome data and technology offerings, thereby fueling the development of advanced kits capable of managing complex matrices.

Additionally, technological breakthroughs in Next-Generation Sequencing are accelerating market expansion by creating a need for upstream solutions that align with the high throughput and sensitivity of contemporary platforms. As sequencing tools evolve to offer lower costs and higher data yields, they create processing bottlenecks that can only be alleviated by automated, efficient sample preparation systems. The strong financial performance of key players highlights this dynamic; Oxford Nanopore Technologies reported a 28.0% constant currency revenue increase in its interim results for the period ending June 2025, while Illumina posted quarterly revenue of $1.08 billion in October 2025. These figures underscore the essential role of reliable sample preparation in supporting the growing genomic profiling ecosystem.

Market Challenge

The primary obstacle facing the Global Microbiome Sample Preparation Technology Market is the lack of universal standardization regarding sample collection and processing methodologies. This inconsistency creates a severe bottleneck by undermining data integrity and reproducibility; when laboratories employ different extraction kits or stabilization methods, the resulting microbial profiles often vary significantly, making it difficult to differentiate between genuine biological signals and technical artifacts. According to a 2024 survey by the Pistoia Alliance, 48% of life science experts identified the lack of metadata standardization as a major impediment to the effective use of experimental data in research and development, preventing the cross-study comparisons required to validate clinical biomarkers.

Consequently, this variability impedes market progress by stalling regulatory approvals and commercialization efforts. Regulatory authorities demand robust, reproducible data to confirm the safety and efficacy of microbiome-based diagnostics and treatments, yet manufacturers struggle to prove this consistency without unified protocols. This uncertainty discourages investment and retards the adoption of sample preparation technologies within clinical environments, ultimately restricting the market's overall revenue potential.

Market Trends

The development of specialized extraction solutions for low-biomass environments is transforming the market by resolving difficulties associated with processing samples containing minimal microbial content, such as skin and blood. Conventional kits often face challenges with high host-to-microbial DNA ratios in these matrices, creating a need for sensitive, optimized protocols to secure high-quality data. This technical requirement is spurring strategic partnerships focused on improving extraction efficiency; for example, in November 2024, Qiagen and McGill University announced a collaboration to co-develop methods tailored for low-biomass samples, aiming to better address the needs of the $1.8 billion North American microbiome research sector.

Concurrently, the utilization of microfluidic technologies for single-cell microbiome preparation is increasing as researchers strive to uncover heterogeneity often missed by traditional bulk sequencing. By isolating individual bacteria within microfluidic droplets, these platforms facilitate the precise mapping of strain-specific gene expression and metabolic functions within complex communities. As highlighted in a December 2024 article on emerging technologies, M20 Genomics revealed that its VITA single-cell transcriptome platform has processed over 7,000 microbial samples worldwide, illustrating the scalability and rapid uptake of these workflows to distinguish functional variations across diverse species.

Key Market Players

• Illumina
• QIAGEN
• Thermo Fisher Scientific
• Zymo Research
• Molzym
• Omega Bio-tek
• Promega
• PerkinElmer
• New England Biolabs
• Kapa Biosystems

Report Scope

In this report, the Global Microbiome Sample Preparation Technology Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Microbiome Sample Preparation Technology Market, By Product

• Instruments
• Consumables

Microbiome Sample Preparation Technology Market, By Workflow

• Sample Extraction/Isolation
• Sample Quantification
• Quality Control
• Fragmentation
• Library Preparation
• Target Enrichment
• Library Quantification
• Pooling

Microbiome Sample Preparation Technology Market, By Application

• DNA Sequencing
• Whole-Genome Sequencing
• RNA Sequencing
• Methylation Sequencing
• Metagenomics
• Single Cell Sequencing
• Others

Microbiome Sample Preparation Technology Market, By Disease Type

• Autoimmune Disorder
• Cancer
• Gastrointestinal Disorders
• Others

Microbiome Sample Preparation Technology Market, By End User

• Pharmaceutical & Biotechnology
• Diagnostic Labs
• Others

Microbiome Sample Preparation Technology Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Microbiome Sample Preparation Technology Market.

Available Customizations:

Global Microbiome Sample Preparation Technology Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Microbiome Sample Preparation Technology Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Instruments, Consumables)
  • 5.2.2. By Workflow (Sample Extraction/Isolation, Sample Quantification, Quality Control, Fragmentation, Library Preparation, Target Enrichment, Library Quantification, Pooling)
  • 5.2.3. By Application (DNA Sequencing, Whole-Genome Sequencing, RNA Sequencing, Methylation Sequencing, Metagenomics, Single Cell Sequencing, Others)
  • 5.2.4. By Disease Type (Autoimmune Disorder, Cancer, Gastrointestinal Disorders, Others)
  • 5.2.5. By End User (Pharmaceutical & Biotechnology, Diagnostic Labs, Others)
  • 5.2.6. By Region
  • 5.2.7. By Company (2025)
• 5.3. Market Map

6. North America Microbiome Sample Preparation Technology Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Workflow
  • 6.2.3. By Application
  • 6.2.4. By Disease Type
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Microbiome Sample Preparation Technology Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Workflow
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By Disease Type
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Microbiome Sample Preparation Technology Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Workflow
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By Disease Type
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Microbiome Sample Preparation Technology Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Workflow
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By Disease Type
      • 6.3.3.2.5. By End User

7. Europe Microbiome Sample Preparation Technology Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Workflow
  • 7.2.3. By Application
  • 7.2.4. By Disease Type
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Microbiome Sample Preparation Technology Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Workflow
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By Disease Type
      • 7.3.1.2.5. By End User
  • 7.3.2. France Microbiome Sample Preparation Technology Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Workflow
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By Disease Type
      • 7.3.2.2.5. By End User
  • 7.3.3. United Kingdom Microbiome Sample Preparation Technology Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Workflow
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By Disease Type
      • 7.3.3.2.5. By End User
  • 7.3.4. Italy Microbiome Sample Preparation Technology Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Workflow
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By Disease Type
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Microbiome Sample Preparation Technology Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Workflow
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By Disease Type
      • 7.3.5.2.5. By End User

8. Asia Pacific Microbiome Sample Preparation Technology Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Workflow
  • 8.2.3. By Application
  • 8.2.4. By Disease Type
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Microbiome Sample Preparation Technology Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Workflow
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By Disease Type
      • 8.3.1.2.5. By End User
  • 8.3.2. India Microbiome Sample Preparation Technology Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Workflow
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By Disease Type
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Microbiome Sample Preparation Technology Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Workflow
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By Disease Type
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Microbiome Sample Preparation Technology Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Workflow
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By Disease Type
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Microbiome Sample Preparation Technology Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Workflow
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By Disease Type
      • 8.3.5.2.5. By End User

9. Middle East & Africa Microbiome Sample Preparation Technology Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Workflow
  • 9.2.3. By Application
  • 9.2.4. By Disease Type
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Microbiome Sample Preparation Technology Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Workflow
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By Disease Type
      • 9.3.1.2.5. By End User
  • 9.3.2. UAE Microbiome Sample Preparation Technology Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Workflow
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By Disease Type
      • 9.3.2.2.5. By End User
  • 9.3.3. South Africa Microbiome Sample Preparation Technology Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Workflow
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By Disease Type
      • 9.3.3.2.5. By End User

10. South America Microbiome Sample Preparation Technology Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Workflow
  • 10.2.3. By Application
  • 10.2.4. By Disease Type
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Microbiome Sample Preparation Technology Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Workflow
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By Disease Type
      • 10.3.1.2.5. By End User
  • 10.3.2. Colombia Microbiome Sample Preparation Technology Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Workflow
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By Disease Type
      • 10.3.2.2.5. By End User
  • 10.3.3. Argentina Microbiome Sample Preparation Technology Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Workflow
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By Disease Type
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Microbiome Sample Preparation Technology Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Illumina
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. QIAGEN
• 15.3. Thermo Fisher Scientific
• 15.4. Zymo Research
• 15.5. Molzym
• 15.6. Omega Bio-tek
• 15.7. Promega
• 15.8. PerkinElmer
• 15.9. New England Biolabs
• 15.10. Kapa Biosystems

16. Strategic Recommendations

17. About Us & Disclaimer